Menu
  • Home
  • About
  • Distributors
  • Investors
Pressure BioSciences Inc
Menu
  • Technology
  • Products
  • Publications
  • Contract Services
  • Contact

Press Releases

Investors
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Audio and Video
    • Email Alerts
  • Company Info
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All Filings
    • Annual Reports
    • Proxy Statements
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

News / Events

  • Press Releases
  • IR Calendar
  • Audio and Video
  • Email Alerts

Unique Advantages and Commercial Process Scalability of Pressure BioSciences Revolutionary UST Platform Illuminated at the Conference of Food Engineering 2022

Sep 27, 2022

Pressure BioSciences to Expand on Pivotal Change in Business Strategy with Presentation at H. C. Wainwright Annual Global Investment Conference on September 13th

Sep 13, 2022

Pressure BioSciences Secures Pivotal Cosmeceuticals Partnership for UST Platform With Dr. Denese SkinScience, 20-Year Leader With Over $0.5 Billion in QVC Sales

Aug 24, 2022

Pressure BioSciences Announces Contract for October 2022 Launch of Breakthrough Hemp-Derived CBD Product, Estimating $2 Million Incremental 2023 Revenue

Aug 18, 2022

Pressure BioSciences, Inc. to Discuss Second Quarter 2022 Financial Results and Provide Business Update

Aug 16, 2022

Pressure BioSciences Announces Approval to Manufacture Hemp-Derived CBD Products in Massachusetts, Including Their Revolutionary CBD Nanoemulsions

Aug 11, 2022

Pressure BioSciences Doubles Growth Projections for UST Nanoemulsion Contracts Following Clear Confirmation of Unmet Needs in Exploding Cannabis Drinks Sector

Aug 5, 2022

Pressure BioSciences Announces Second Contract for Toll Manufacturing of a CBD Nanoemulsion Product Using Its Proprietary Ultra Shear Technology Platform

Jul 21, 2022

Pressure BioSciences to Expand on Upcoming Release of CBD Nanoemulsion Oral Spray at July 6th Emerging Growth Conference - Annual Revenue to PBI Expected to Exceed $1M

Jul 6, 2022

Pressure BioSciences to Participate in FORCE Family Office June 30th Webinar: Revolutionizing the Development of Plant-Based Food Products

Jun 30, 2022
RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...42

    Browse Our Site

    • Home
    • About
    • Distributors
    • Investors
    • Technology
    • Products
    • Publications
    • Contract Services
    • Contact

    Visit Us

    • Corporate Office
    • Pressure BioSciences, Inc.
    • 14 Norfolk Avenue
    • South Easton, MA 02375
    • Research & Development Laboratory
    • Pressure BioSciences, Inc.
    • Suite 1950
    • 200 Boston Avenue
    • Medford, MA 02155

    Connect With Us

    Talk To Us

    • P (508) 230.1828
    • F (508) 230.1829
    • E info@pressurebiosciences.com
    • SEND US A MESSAGE
    • Privacy Policy
    • Returns & Refunds
    • Terms & Conditions/Delivery & Shipment
    • Disclaimer

    © 2023 Pressure BioSciences, Inc. All Rights Reserved. Website by Interactive Palette